These findings suggested that cedrol upregulated p-p53/p21 expression and downregulated CDK4/cyclin D1 expression and contributed to the suppression of CRC cells by cedrol-induced G0/G1 arrest. The gene discussed is TP53; the disease is colorectal carcinoma.